Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMetals Exploration Regulatory News (MTL)

Share Price Information for Metals Exploration (MTL)

Share Price is delayed by 15 minutes
Get Live Data
13.20    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.30 (2.308%)
Market Cap: £393.37m
MTL Live PriceLast checked at - London Stock Exchange

Intraday Metals Exploration Share Chart

Runruno Scoping Study Update

15 Jul 2008 07:00

RNS Number : 0459Z
Metals Exploration PLC
15 July 2008
 



Metals Exploration PLC

Runruno Scoping Study - Update

BIOX® selected as preferred process route

15 July 2008

Metals Exploration PLC ('Metals Ex' or 'the Company'), the natural resources exploration and development Company with assets in the Pacific Rim region, is pleased to provide an update on the progress of the Scoping Study being conducted on its Runruno gold-molybdenum deposit in the Philippines.

Highlights:

BIOX® technology selected as the preferred processing technology following a detailed assessment of the gold and potential molybdenum recovery and the likely capital and operating costs. 

Ausenco well advanced in process design and capital and operating cost estimation.

Diamond and RC drilling completed for this stage.

Design and costing of infrastructure components proceeding well with no fatal flaws identified.

Study expected to be finalised in late August - early September

Processing 

BIOX® processing technology has been selected as the preferred technology to be used in the oxidisation circuit for processing ore at Runruno.

Both BIOX® and Pressure Oxidation (POX) technologies have been shown by test-work to be equally applicable to processing Runruno ores with excellent gold recovery and good dissolution of molybdenum. In order to assess the application of the technologies to Runruno and to provide a basis for selecting a preferred processing route, the Company commissioned Gold Fields Mining Services to undertake a study on the capital (Capex) and operating (Opex) costs and the benefits and disadvantages of the BIOX® technology. Similarly, a study of the POX technology was undertaken by Ausenco.

The results of these comparative studies have shown that the Capex and Opex cost regime estimated for BIOX® technology is significantly lower than that estimated for POX; with BIOX® Capex estimated at about 50% and Opex at about 66% of that estimated for POX. Analysis of the benefits and disadvantages of the two technologies has shown BIOX® to be of a lower operating risk and more suited to the application proposed.

As a direct consequence of the finalisation of the gold processing route, molybdenum recovery test-work will now be focussed on a chemical recovery process rather than a physical process such as recovery into a saleable flotation concentrate. To date, BIOX® test-work has been encouraging with up to 78% of the molybdenum contained in concentrate being dissolved during oxidation. When combined with recoveries into the flotation concentrate, the Company is targeting overall molybdenum recoveries of around 50%, implying annual production of approximately 2 mlbs Mo per annum.

The ongoing test-work program will now focus on the recovery of the molybdenum from solution and the optimisation of the dissolution of the molybdenum. Work has commenced on this program.

Process Design

Ausenco is well advanced with process design and the Capex and Opex estimates for the processing plant. The metallurgical circuit and layout is proving to be relatively straightforward, and now that BIOX® has been chosen as the preferred process route the circuit is likely to share a number of similarities with Sino Gold's Jinfeng mine in China.

It is expected that this component of the study will be completed during August.

Resource Drilling

The drilling program designed to support the Scoping Study is now complete. All of the holes have been sampled and submitted for assay with about half returned to date. The majority of the holes completed were in-fill holes designed to add certainty to the resource estimate. 

Once all the assay data has been received and the geological interpretation and model confirmed the mineral resource will be re-estimated. Subject to receipt of assay data the resource update should be available by the end of August. This updated resource will then be used as a base to finalise mine planning.

Drilling using three diamond drill rigs is continuing on the boundaries of the resource.

Infrastructure

Infrastructure studies are proceeding well with no fatal flaws identified. Parsons Brinkerhoff and GHD along with a number of other Philippine based specialists have been retained by the Company to assist with these works.

Scoping Study

The Scoping Study is proceeding satisfactorily after some delays caused by the unsatisfactory performance of the drilling contractor during the early stages of the program and the widespread shortage of senior experienced technical resources endemic in the industry. Both these issues have been successfully addressed.

It is now expected that the study will be finalised late in August - or early September.

Jonathan Beardsworth, Chief Executive of Metals Ex, said: 

"It is pleasing to be able to report that the Scoping Study is making such good progress across a range of disciplines - in-fill drilling, resource update, mineplanning, selection of process route, likely moly recoveries, and infrastructure studies.

Our confidence in the resource and the likelihood of being able to develop a mine at Runruno grows with every report received"

For more information:

 

Jonathan Beardsworth + 44 (0) 20 7927 6690

CEO + 44 (0) 7747 101 552Tim Feather +44 (0) 20 7601 6100

Hanson Westhouse

Charles Vivian + 44 (0) 20 7743 6672Pelham PR

Klara Kaczmarek + 44 (0) 20 3159 4395Pelham PR

QUALIFIED/COMPETENT PERSONS

Mr Ian Holzberger, who is the Project Director for the development of the Runruno Project and a Director of the Company, has been involved in the mining and exploration industry for more than 35 years. He has compiled, read and approved the technical disclosure in this regulatory announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLGDRCXBGGIS
Date   Source Headline
8th Oct 202411:28 amRNSMajor Shareholdings
2nd Oct 202411:38 amRNSChange of Registered Office
26th Sep 202410:50 amRNSBuy Back, TVR and Major Shareholdings
23rd Sep 20247:00 amRNSInterim Results for six months ended 30 June 2024
9th Sep 20247:00 amRNSTotal Voting Rights and Major Shareholdings
3rd Sep 202412:03 pmRNSDirectorate Change
2nd Sep 20242:54 pmRNSBuy Back of Ordinary Shares & Total Voting Rights
28th Aug 20247:00 amRNSCompletion of YMC Acquisition
23rd Aug 202412:00 pmRNSResult of General Meeting
6th Aug 202412:52 pmRNSPublication of Circular and Notice of GM
19th Jul 202410:36 amRNSQuarterly Update to 30 June 2024
28th Jun 202412:21 pmRNSResult of AGM
21st Jun 20243:45 pmRNSHolding(s) in Company
21st Jun 20243:45 pmRNSHolding(s) in Company
20th Jun 20242:25 pmRNSExercises of Options, PDMR Dealings and TVR
20th Jun 20247:00 amRNSProposed Buy Back of RHL Shares
5th Jun 20244:18 pmRNSPosting of Annual Report and Notice of AGM
23rd May 20247:00 amRNSFinal Results for the Year Ended 31 December 2023
22nd May 20247:00 amRNSPublication of Fourth Sustainability Report
9th May 20247:00 amRNSUpdate on Debt Discussions
29th Apr 20247:00 amRNSQuarterly Update to 31 March 2024
25th Apr 202410:18 amRNSHolding(s) in Company
5th Apr 20242:00 pmRNSExercise of Options, PDMR Dealing and TVR
27th Mar 20247:00 amRNSUpdate on Debt Facilities
18th Mar 20247:00 amRNSAppointment of Chairman
5th Feb 202412:01 pmRNSInvestor Presentation
24th Jan 20247:00 amRNSQuarterly Update to 31 December 2023
12th Jan 20247:00 amRNSAcquisition of Prospective Philippine Exploration
14th Dec 20232:00 pmRNSExercise of Options and Total Voting Rights
11th Dec 20237:00 amRNSReceipt of Awards
1st Dec 20237:00 amRNSAppointment of New Auditor
17th Oct 20237:00 amRNSQuarterly Update To 30 September 2023
27th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSDirector Resignation
20th Jul 20237:00 amRNSQuarterly Update to 30 June 2023
19th Jun 20234:45 pmRNSResult of AGM
22nd May 20234:30 pmRNSPosting of Annual Report and Notice of AGM
16th May 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
9th May 202310:51 amRNSMine Site Incident
28th Apr 20237:00 amRNSQuarterly update to 31 March 2023
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
31st Jan 20237:00 amRNSQuarterly Update to 31 December 2022
9th Nov 20227:00 amRNSReceipt of Presidential Award
14th Oct 20227:00 amRNSQuarterly Update to 30 September 2022
14th Sep 20227:00 amRNSInterim Results
29th Jul 20228:56 amRNSReduction of Capital Effective
21st Jul 20227:00 amRNSUpdate on Reduction of Capital
20th Jul 20227:00 amRNSQuarterly Update to 30 June 2022
17th Jun 20223:26 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.